Dr Eagle Rx Blog - Cancer Network

NEWS

Soluble HER2 Levels Prognostic Factor in HER2+ Breast Cancer
June 19, 2013

ASCO: PD-L1 Antibody Elicits Durable Response in RCC
June 19, 2013

RECORD-3: Sunitinib Still Standard First-Line Treatment in Metastatic RCC
June 19, 2013

ASCO: Dabrafenib Shows Activity in BRAF-Mutated NSCLC Patients
June 18, 2013

CONNECT WITH US

	Become a fan on Facebook
	Add us on Google Plus
	Follow us on Twitter
	Join us on LinkedIn
	Sign up for our Newsletters
	Subscribe to our RSS Feed

DR EAGLE RX

Solutions to Current Health Updates: In this new blog Dr. David Eagle, MD, president of the Community Oncology Alliance, shares his thoughts on current health care problems and potential solutions.

Ending the Shortage of Generic Oncology Drugs
November 17, 2011

Nationally, the number of drug shortages has tripled since 2005. Other generic drug shortages in our clinic have included paclitaxel, leucovorin, and doxorubicin. We have had limited ability to order fluorouracil (5-FU) and mitomycin.

BLOGGERS

	CHEERFUL ONCOLOGIST Craig R. Hildreth
	DR EAGLE RX David Eagle
	ETHICS AND ONCOLOGY Paul R. Helft
	HEMATOLOGY LETTERS Mojtaba Akhtari
	MOBILE HEALTH UPDATE The iMedicalApps Editors
	MUSINGS OF A CYNICAL CURMUDGEON Frederic W. Grannis Jr.
	ONCOLOGIST PERSPECTIVES L. Michael Glodé

TOPIC INDEX

Cancer Types
Breast Breast (HER2+) Breast (Triple-Negative) CML Colorectal Gastrointestinal GIST Genitourinary Gynecologic Head & Neck	Hematology Kidney (Renal Cell) Leukemia Lung Lymphoma Melanoma Multiple Myeloma Ovarian Prostate Sarcoma
Supportive Care	More Topics
Bone Metastases End-of-Life Care Palliative Care	Ethics in Oncology Practice Management Practice & Policy

All Topics